Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (24585)	8/16/1998 10:46:00 PM
From: RXGOLF	Read Replies (1) \| Respond to of 32384

Good evening Dr. <<I think that the milestone payments and new deals will improve LGND's balance sheet significantly>> I have been under the impression that no further dilutions would be needed before profitability was indeed achieved. The milestone payments and new deals fore mentioned in your writing may well provide all the funding LGND needs to reach profitability, and this would be consistent with goals I believe LGND management has set. I hope the E-mails you mention are indeed filled with enough substantial information to persuade you to continue your constant support of this company. My hopes are that LGND deserves all of the shareholders patience they have had to show these last few months. Certainly LGND is not the only biotech beaten down, and of course biotechs are not the only beaten down sector.(have you looked at the oil sector of late?) This being true however, does not provide LGND with an excuse not to become profitable on schedule and fulfill every other intention that has been presented to their shareholders. Thank you any updates you can supply, Greg